FDA Approves New Pill For Advanced Breast Cancer Guided By Blood Test
TUESDAY, Sept. 8, 2026— The U.S. Food and Drug Administration (FDA) has approved a new daily pill for adults with advanced breast cancer whose tumors have found a way around their current treatment.The drug, Etcamah (camizestrant), is taken...
Read more »